Cargando…

l‐Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior

OBJECTIVE: In Parkinson's disease (PD), effects on behavior and cognition of levodopa/carbidopa intestinal gel (LCIG) and subthalamic stimulation (STN‐DBS) and their practical consequences remain controversial. This study was designed to analyze the possible effects of these therapies on cognit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valldeoriola, Francesc, Santacruz, Pilar, Ríos, José, Compta, Yaroslau, Rumià, Jordi, Muñoz, José Esteban, Martí, María José, Tolosa, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698866/ https://www.ncbi.nlm.nih.gov/pubmed/29201549 http://dx.doi.org/10.1002/brb3.848

Ejemplares similares

Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report
por: Torres, Viviana, et al.
Publicado: (2022)

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
por: Valldeoriola, Francesc, et al.
Publicado: (2021)

Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Fernández-Santiago, Rubén, et al.
Publicado: (2021)

The Role of the Subthalamic Nucleus in L-DOPA Induced Dyskinesia in 6-Hydroxydopamine Lesioned Rats
por: Aristieta, Asier, et al.
Publicado: (2012)

Comparison Between Levodopa-Carbidopa Intestinal Gel Infusion and Subthalamic Nucleus Deep-Brain Stimulation for Advanced Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Liu, Xiao Dong, et al.
Publicado: (2019)

Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy
por: Abos, Alexandra, et al.
Publicado: (2019)

Patterns of cortical thinning in nondemented Parkinson's disease patients
por: Uribe, Carme, et al.
Publicado: (2016)

Discriminating cognitive status in Parkinson’s disease through functional connectomics and machine learning
por: Abós, Alexandra, et al.
Publicado: (2017)

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects
por: Schneider, Frank, et al.
Publicado: (2018)

How I do it — asleep DBS placement for Parkinson’s disease
por: Roldan, Pedro, et al.
Publicado: (2023)

Disrupted functional connectivity in PD with probable RBD and its cognitive correlates
por: Oltra, Javier, et al.
Publicado: (2021)

Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer
por: Barrantes, Sergi, et al.
Publicado: (2017)

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Dose-dependent L-dopa/carbidopa-induced hyponatremia presenting with hiccups
por: Shihabudheen, P., et al.
Publicado: (2020)

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
por: Othman, Ahmed A., et al.
Publicado: (2017)

Statistical inference in brain graphs using threshold‐free network‐based statistics
por: Baggio, Hugo C., et al.
Publicado: (2018)

Long‐term safety and effectiveness of levodopa‐carbidopa intestinal gel infusion
por: De Fabregues, Oriol, et al.
Publicado: (2017)

Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation
por: Kimber, Thomas Edmund, et al.
Publicado: (2019)

Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy
por: Loens, Sebastian, et al.
Publicado: (2017)

Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers
por: Garrido, Alicia, et al.
Publicado: (2022)

Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson’s Disease
por: Garcia-Diaz, Anna Isabel, et al.
Publicado: (2017)

L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study
por: Stocchi, Fabrizio, et al.
Publicado: (2015)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure
por: Bautista, Juan Miguel Pilar, et al.
Publicado: (2020)

Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?
por: Catalán, Maria José, et al.
Publicado: (2017)

(123)I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations
por: Valldeoriola, Francesc, et al.
Publicado: (2011)

Sex Differences in Brain and Cognition in de novo Parkinson's Disease
por: Oltra, Javier, et al.
Publicado: (2022)

Implementation of Exome Sequencing in Clinical Practice for Neurological Disorders
por: Alvarez-Mora, María Isabel, et al.
Publicado: (2023)

Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers
por: Pont-Sunyer, Claustre, et al.
Publicado: (2015)

Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics
por: Standaert, David G., et al.
Publicado: (2018)

Proposition of zinc supplementation during levodopa–carbidopa intestinal gel treatment
por: Matsuyama, Hirofumi, et al.
Publicado: (2018)

Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice
por: Öthman, Mezin, et al.
Publicado: (2021)

Impaired Structural Connectivity in Parkinson's Disease Patients with Mild Cognitive Impairment: A Study Based on Probabilistic Tractography
por: Inguanzo, Anna, et al.
Publicado: (2021)

Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus
por: Gulberti, A., et al.
Publicado: (2015)

Gray/White Matter Contrast in Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
por: Lang, Anthony E., et al.
Publicado: (2015)

Effect of levodopa‐carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
por: Antonini, Angelo, et al.
Publicado: (2016)

Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety
por: Poewe, Werner, et al.
Publicado: (2019)

Problems related to levodopa‐carbidopa intestinal gel treatment in advanced Parkinson's disease
por: Udd, Marianne, et al.
Publicado: (2017)

Multicenter study of levodopa carbidopa intestinal gel in Parkinson’s disease: the Turkish experience
por: GÜLTEKİN, Murat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_00drdeeoa8noebg7qsf1o352q5